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A carboxypeptidase E (CPE) knockout (KO) mouse was gen-
erated by deletion of exons 4 and 5 from the CPE gene, and its
phenotype was characterized. KO mice became obese by 10–12
wk of age and reached 60–80 g by 40 wk. At this age, body fat
content was more than double that in the wild-type (WT) con-
trols. The null animals consumed more food overall, were less
physically active during the light phase of the light-dark cy-
cle, and burned fewer calories as fat than WT littermates.
Fasting levels of glucose and insulin-like immunoreactivity in
plasma were elevated in both male and female KO mice at
approximately 20 wk; males recovered fully and females par-
tially from this state by 32 wk. At this time, insulin-like im-
munoreactivity in the plasma, identified as proinsulin, was
50–100 times higher than that of the WT animals. The KO mice
showed impaired glucose clearance and were insulin resis-
tant. High levels of leptin and no circulating fully processed
cocaine- and amphetamine-related transcript, a peptide that
is responsive to leptin-induced feedback inhibition of feeding,
were found in serum. The KO mice were subfertile and showed
deficits in GnRH processing in the hypothalamus. Behavioral
analyses revealed that KO animals showed diminished reac-
tivity to stimuli and had reduced muscle strength and coor-
dination, as well as visual placing and toe-pinch reflexes.
These data demonstrate that CPE KO mice display a wide
range of neural and endocrine abnormalities and suggest that
CPE may have additional physiological roles beyond those
ascribed to peptide processing and sorting of prohormones in
cells. (Endocrinology 145: 5807–5819, 2004)
CARBOXYPEPTIDASE E (CPE) is a prohormone pro-cessing exopeptidase and a prohormone sorting re-
ceptor for the regulated secretory pathway (RSP) in endo-
crine and neuroendocrine cells (1–4). Peptide hormones and
neuropeptides are synthesized as larger precursors that are
first cleaved by prohormone convertases, either in between
or on the carboxyl side of paired basic residues to yield basic
residue-extended peptides (5–7). Within secretory granules
of the RSP, CPE then cleaves the basic residues from these
hormone and neuropeptide intermediates to generate bio-
active peptides (1, 8). Aside from soluble CPE, the membrane
form has also been shown to act as a receptor for sorting
prohormones away from other non-RSP proteins at the trans-
Golgi network (TGN), and into secretory granules in the RSP
of pituitary (3, 9), and pancreatic -cells (10), as well as in
neuronal cell lines (11). The transmembrane form of CPE can
be anchored to cholesterol/sphingolipid-rich microdomains
known as lipid rafts or detergent-resistant membranes at the
TGN (12–14). It acts as a sorting receptor at the TGN by
binding to a specific sorting motif on the prohormone and
bringing it into the immature granule as it buds off the TGN
membrane. In pancreatic -cells where sorting of proinsulin
from other non-RSP proteins continues in the immature
granule, CPE can act as a retention receptor to retain insulin
within this organelle and prevent its removal via the
constitutive-like pathway (15). Upon exocytosis, membrane
CPE in secretory granules is internalized by a novel mech-
anism requiring the physical interaction of its cytoplasmic
tail with ADP-ribosylation factor 6, a GTPase (16). CPE is
then recycled back to the TGN for reuse as a sorting receptor
or processing enzyme. These properties suggest that the C-
terminal tail of CPE may perform some role in endocytosis,
a suggestion recently supported by data showing the re-
quirement for CPE in the endocytosis of eosinophil cationic
protein in neuroendocrine cells (17).
CPE mis-sense polymorphisms have been found in pa-
tients with type 2 diabetes mellitus (18). In four different
families, the R238W mutation altered CPE enzymatic activity
and the patients showed early onset of type 2 diabetes. An-
other CPE mutation (e.g. S202P) was found in mice. These
Cpefat/Cpefat mice were obese, infertile, and developed hy-
perproinsulinemia (19, 20). Mutant CPE in these mice was
primarily in the precursor form and was differentially de-
graded in various tissues (20, 21). In pituitary cells, mutant
CPE molecules were essentially all degraded, whereas in
pancreas, they were partially degraded, and the undegraded
molecules were trafficked from the endoplasmic reticulum to
the TGN and packaged into secretory granules (21). Thus,
because of the presence of residual mutant CPE in various
tissues, this mouse may represent an inadequate null model
for studies of CPE function. In Caenorhabditis elegans, a CPE
Abbreviations: CART, Cocaine- and amphetamine-related transcript;
CPE, carboxypeptidase E; ES, embryonic stem; HET, heterozygous; IR,
immunoreactivity; KO, knockout; RSP, regulated secretory pathway;
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null mutant has been reported to exhibit deficient acetyl-
choline release at the neuromuscular junction implicating,
perhaps, yet another nonenzymatic role of CPE in neuro-
transmission (22).
In view of the evidence that CPE may have additional roles
besides that of a prohormone processing enzyme, it was
important to generate a true CPE null or knockout (KO)
mouse to study the loss-of-function phenotype of CPE. Such
a mouse would be a valuable model for the study of type 2
diabetes and other diseases involving defective peptide hor-
mone processing and trafficking. In this study, we generated
a CPE KO mouse and characterized its phenotype with re-
spect to its endocrine and behavioral functions in the whole
animal.
Materials and Methods
Generation of the CPE knockout mouse
A targeting vector was generated from a 129Sv genomic mouse bac-
teria artificial chromosome clone (Research Genetics, Huntsville, AL)
containing the Cpe gene. Exons 4 and 5 (encoding the enzymatic active
site and the sorting signal binding domain of CPE) were floxed and
flanked with a 2.2-kb EcoRV-EcoRI 5arm followed by a loxP-neo-tk
cassette and a 7.1-kb XhoI-BamHI 3 arm (Fig. 1, left). The NotI linearized
construct was electroporated into W9.5 embryonic stem (ES) cells. The
correctly targeted ES clone (normal karyotype) was electroporated with
Cre recombinase to generate ES clones devoid of exons 4, 5, and the
neo-tk cassette. The null CPE ES clones (normal karyotype) were micro-
injected into C57BL6 blastocysts. Chimeras from the mixed background
(C57BL6/129Sv) were obtained and gave germline transmission. Het-
erozygous (HET) mutant mice were bred and mated to generate ho-
mozygous mutants. All mice studied here were from first and second
generation backcross with C57BL6 mice and KO animals were compared
with their wild-type (WT) littermates or age matched mice from breed-
ing pairs with equivalent genetic backgrounds. All experiments were
conducted with approved animal protocols at the National Institutes of
Health and Duke University Medical Center.
Genotyping
Genomic DNA was extracted from tail snippets by standard proce-
dures and subjected to PCR using a mixture of three primers (primer 1:
5-GTAGCCTGGGTTGGAATCCTCGGCTATGTA-3, primer 2: 5-AG-
GAAAGATCACAAGACTCAGAAGCTGACAATCGC-3, primer 3: 5-
CAGTAATGGGCCTGGACTTGTAATCCTTGTAGC-3). The HotStar-
Taq PCR kit was used (QIAGEN, Germantown, MD) and the PCR run
with the following program: 94 C for 5 min followed by 35 cycles at 94
C for 30 sec, 68 C for 30 sec, and 72 C for 3 min. The KO allele generated
an approximately 1.6-kb band from primers 1 and 3, whereas the WT
allele produces a band at approximately 1.0 kb from primers 1 and 2
(data not shown). The location of the primers that generates these bands
is shown in Fig. 1, left panel.
Western blot
Whole pituitaries were dissected from WT, HET, and KO mice and
immediately frozen on dry ice until analyzed. After thawing, by the
addition of 1 SDS-PAGE sample buffer with reducing agent, a stan-
dard Western blotting procedure was used for the analysis of CPE from
equivalent volumes of the homogenates. Rabbit anti-CPE antibody 7–8,
generated in our laboratory (3) was used.
Food, water, and O2/CO2 consumption
At approximately 12 and 30 wk of age, food and water consumption
were monitored over 3 d for WT and KO mice in a Columbus Instru-
ments system (Columbus, OH) that measures moment-to-moment food
intake in grams and water consumption as licks or volume. Because
older KO mice were too large to traverse the chute to the food tray, food
and water intake were measured in the home cages at the beginning and
end of each light-dark cycle (lights on 0600–2000 h) for both WT and KO
animals. O2/CO2 consumption was measured from the same 12- and
30-wk old WT and KO mice by the Oxymax system (Columbus Instru-
ments) over 6 h during the light period. The respiratory quotient was
calculated for each individual animal as the ratio of CO2 production to
O2 consumption during periods of low activity (10 activity events in
a 10-min period over the last 2 h of testing). Energy expenditure was
calculated as [(3.815  1.232)  VCO2/VO2)  VO2] where VCO2 is the
expired CO2 volume at ml/kgh and VO2 is the expired O2 volume in
the same units (see Ref. 23).
Spontaneous activity
To assess activity, animals at approximately 12 and 30 wk of age were
first adapted to the room for 2 h. Horizontal, vertical, and stereotypical
activities in the open field (OF; 21  21  30 cm) were monitored by
photobeams for 24 h (lights on 0600–2000 h at 340 lux) and food and
FIG. 1. Diagram showing deletion of murine Cpe and Western blot. Left, CPE construct showing exon 4 and exon 5 which were deleted in vitro
by Cre recombinase. Primers for genotyping are depicted. Right, Western blot analysis of equivalent volumes (25%) of whole pituitary
homogenates showing the presence of CPE in WT and HET animals, and its absence in the null (KO) animals.


















Y user on 15 O
ctober 2021
water were available ad libitum. Locomotor (horizontal distance in cen-
timeters), vertical (counts), and stereotypical (repetitive beam breaks 1
sec apart) activities were analyzed with the VersaMax program (Accu-
Scan Instruments, Columbus, OH). To assess motor abilities of 15-wk-
old mice in a new environment, animals were placed in the center of a
similar OF (40  40  35 cm) and given free exploration for 15 min.
Horizontal and vertical movements were again counted as beam breaks.
Magnetic resonance imaging
Male and female WT and CPE KO mice (47–52 wk of age) were
weighed and placed into the chamber of a MiniSpec NMR Analyzer
(Bruker Optics, Inc., Billerica, MA), which determines total fat content.
The weight of total fat for each mouse was converted to percent total
body weight and averaged for each group.
ProteinChip profiling analysis of cocaine- and
amphetamine-related transcript (CART) processing
The ProteinChip antibody capture kit (Ciphergen Biosystems, Fre-
mont, CA) was used for the detection of CART proteins directly from
the sera of WT and CPE KO mice. Briefly, according to the manufac-
turer’s instructions, 1 l of polyclonal CART (55–102) antibody (Phoenix
Pharmaceuticals, Belmont, CA) was bound to recombinant Protein G
that was precoupled to spots on the chips. After this, 2 l of 100 diluted
serum and 2 l of binding buffer were added to individual spots on
the chips and incubated for 1 h. After the incubation, the chips were
washed twice with binding buffer, twice with PBS, and finally rinsed
with water and air dried. The bound proteins were coated with the
energy-absorbing matrix (cyno-4-hydroxy cinnapinic acid) and ana-
lyzed by surface-enhanced laser desorption/ionization-time of flight
mass spectrometry using the Ciphergen ProteinChip reader. Negative
control experiments (without antibodies or without serum) were run
concurrently to control for experimental variations. All steps were per-
formed at room temperature.
Serum leptin contents
Leptin levels were determined in nonfasted WT and CPE KO mice.
Blood samples were collected in serum separator tubes, centrifuged
immediately at 600  g at 4 C for 10 min, and the serum collected,
aliquoted, and stored at 20 C. Leptin was assayed directly from serum
using a mouse leptin RIA kit (Linco Research Inc., St. Charles, MO).
Determination of fasting plasma glucose and insulin-like
immunoreactivity (IR)
CPE KO mice and their WT and HET littermates were removed from
their cages in the early morning and placed in fresh cages with water but
without food for 6–8 h. After this period, blood was collected from the
orbital sinus, plasma was separated from cells and frozen. Plasma glu-
cose levels were determined using a hand-held Accu-Chek Compact
glucometer (Roche Diagnostics Corp., Indianapolis, IN) or a Hemocue
-Glucose Analyzer (Hartman Medical Hemocue, Piano, TX). Fasting
levels of insulin-like IR were determined directly from plasma by RIA
using the Linco sensitive rat insulin kit that cross-reacts with mouse
insulin 100% and with human, bovine, and porcine proinsulin 70–75%.
HPLC analysis of serum (pro)insulin
Fifty microliters of plasma from 27-wk-old WT and CPE KO females
were acidified by addition of glacial acetic acid to 1 m. Samples were
centrifuged at 13,000 rpm for 10 min to remove particulates. Forty
microliters of supernatant from each sample were separated on a 4.6 
250 mm 5 m reversed-phase Jupiter C18 column (Phenomenex, Tor-
rance, CA) as described by Neerman-Arbez and colleagues (24) with
minor modifications (see Fig. 7 legend). Fractions were collected, ly-
ophilized, and reconstituted in RIA buffer and assayed by RIA for
insulin-like IR. Under these conditions, authentic human insulin (Phoe-
nix Pharmaceuticals) eluted in fraction 8 and porcine proinsulin (a gift
from Dr. Knud Vad, Novo Nordisk, Bagsvaerd, Denmark) eluted in
fraction 23.
Glucose and insulin tolerance tests
Male and female CPE KO and WT animals (12 and 30 wk old) were
fasted overnight. After determination of baseline plasma glucose con-
centrations (see above), the animals were weighed and then adminis-
tered a single injection of 25% d-glucose (ip; 11.1 mmol/kg body weight).
Approximately 20 l of blood were collected from the orbital sinus at 15,
30, 60, 120, and 180 min after glucose injection. Plasma was separated
from red blood cells and used in the assay.
A separate group of nonfasted male and female CPE KO and WT mice
at approximately 12 and 30 wk of age were weighed, and an initial
plasma glucose determination was made. The mice were then given 1
U/kg (ip) recombinant human insulin (Novo Nordisk, Clayton, NJ).
Clearance of plasma glucose was subsequently monitored at 15, 30, and
60 min post injection.
Reproductive status and GnRH analysis
Fertility was assessed by pairing naive WT males and females or naive
KO males and females (9 wk age) for 30 d or until the female showed
detectable signs of pregnancy, whichever occurred first. Pregnancy was
monitored daily by visual inspection, palpation, and weight gain. Hy-
pothalamic GnRH-like IR was measured by RIA with two different
antisera after extraction procedures described previously (25–27). The
A772 antiserum recognizes [Gln1]-GnRH and mammalian GnRH but not
intermediates with amino acid extensions at the C terminus (28),
whereas the B9 antiserum binds mammalian GnRH and the interme-
diates, as well as very low recognition for the pro-GnRH (26). All sam-
ples were run in one assay and the intraassay variabilities were ap-
proximately 5%.
Assessment of general health and neurobehavioral status
Mice were housed under standard laboratory conditions with food
and water provided ad libitum. At 15 wk of age, CPE KO mice and their
HET and WT littermates were examined with the SHIRPA phenotypic
behavioral screen as described (29). Observations were scored on gra-
dient scales and are reported in Table 1, where in most cases an in-
creasing number indicates enhanced vigor, strength or excitement ex-
cept where noted (see Table 1 legend). See details at: http://www.
mgu.har.mrc.ac.uk/mutabase/shirpa_summary.html.
Briefly, after an observational period in which body position, spon-
taneous activity, respiratory rate, and unusual behaviors (e.g. tremor or
stereotypy) were assessed, each animal was evaluated for fur condition,
eye opening, piloerection, body and limb tone, posture, and gait. Ad-
ditional assessments (see Table 1) involved increased handling of the
animals, during which indications of fear or aggression were noted. The
same experimenter in the same room under the same conditions tested
all animals, except that one or two additional experimenters assisted in
all studies.
Statistics
The data are presented as means and sem. The statistical analyses
were performed with the Statistical Package for the Social Sciences,
version 11.0 (Chicago, IL) or with StatView software by Abacus Con-
cepts (Berkeley, CA). The body weight data were analyzed by univariate
ANOVA across the 48 wk. Fasting levels of plasma glucose and insulin,
and hypothalamic GnRH contents were evaluated with univariate
ANOVA using a split-plot design with genotype and sex as the fixed
factors. A priori tests for repeated-planned comparisons and reverse-
Helmert contrasts were conducted to identify specific age-dependent
changes in weight, whereas fasting glucose and insulin were examined
as a function of genotype and sex. Glucose and insulin tolerance tests,
feeding and drinking behavior, and spontaneous activity in the open
field were analyzed with repeated measures ANOVA with fixed factors
for genotype, sex, and age. To control for possible effects because of body
weight, the data were also reanalyzed with analysis of covariance using
weight as a covariate. A priori tests for repeated planned comparisons
were used to determine whether changes in glucose occurred at specific
time points between the fixed factors. Measures taken for energy ex-
penditure and respiratory quotients were analyzed with univariate
ANOVAs with fixed factors for genotype, sex, and age. Fertility of WT
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and KO mice were evaluated by 2 tests. The behavioral data were
analyzed with ANOVA followed by comparisons between WT, HET,
and CPE KO animals with Fisher’s protected least significant difference.
For all purposes, statistical significance was defined as P  0.05.
Results
Body weight, body length, and obesity
Mice were studied between 1 and 48 wk of age (Fig. 2).
Weights were recorded daily from postnatal d 1 until post-
natal d 18 (data not shown). At 1–18 d after birth, both male
and female CPE KO mice were generally lighter in weight
than WT mice, but the difference was not statistically sig-
nificant. At 4–7 wk, the weights of the KO mice increased and
approached those of WT animals (Fig. 2). By 8 wk, both male
and female KO mice were heavier than WT mice. For WT
mice, the most significant weight gains occurred between 2
and 6 wk for males and between 1 and 8 wk for females. By
comparison, significant weight gains for KO males were
delayed and occurred between 6 and 8 wk with marginal
increments in body weight occurring after this time. Weight
gains for KO females was also delayed but week-to-week
gains were slow and consistent over time and were not
characterized by rapid increases as seen in the other groups
of mice. By approximately 40 wk of age, the KO animals
weighed 60–80 g and were two to three times heavier than
their WT and HET littermates.
Body length (tip of nose to base of tail) was measured in
mice at 12 and 30 wk of age. Older mice were significantly
longer than younger animals with older KO males growing
more in length than older WT males. No differences were
discerned between WT and KO females.
Food and water consumption
Food and water intake were assessed in CPE mice at ap-
proximately 12 and 30 wk of age (Fig. 3). At 12 wk of age, KO
females consumed more food during the dark phase of the
cycle than the female WT controls (Fig. 3A), whereas WT and
KO males ate similar amounts. By 30 wk, both male and
female KO animals ate more food than their WT littermates
and this was especially apparent during the dark phase of the
cycle (Fig. 3B). Overall, the older mice consumed more food
than the animals at 12 wk with greatest intakes occurring
during the dark phase of the light-dark cycle (Fig. 3, A and
B). Although KO females at 12 wk displayed the largest
change in food intake between the light and dark cycles, the
magnitude of this change was similar to that observed with
older null females. Similar effects were also observed when
the data were reanalyzed controlling for body weight (data
not shown). Water intake was similar to that for food intake
with respect to genotype, age, and sex, except for females
where water intake by older WT and KO females was not
different (data not shown).
Activity and indirect calorimetry
Spontaneous activity was assessed in the OF over 24 h. At
12 wk of age, both male and female WT mice were more
active during the light phase of the light-dark cycle than the
homozygous mutants (Fig. 3C). However, during the dark
phase, WT and KO males were equally active and the KO
females displayed the highest rates of activity. Locomotion
decreased with age, with the KO animals exhibiting lower
levels during the light and dark phases of the cycle compared
TABLE 1. Results of the SHIRPA protocol
/ (n  12) / (n  6) / (n  20)
General health
Eyelid closure (0–2)a 0 0 0.28  0.16
Piloerection (0–1) 0 0 0
Abdominal tone (0–2) 1.0  0 1.0  0 0.75  0.1b
Body tone (0–2) 0.92  0.08 1.0  0 0.65  0.1
Limb tone (0–4) 1.2  0.2 1.3  0.2 1.0  0.2
Tremor (0–2) 0 0 0.45  0.1b
Reflexes
Visual placing (0–4) 2.1  0.1 2.0  0 1.7  0.1c
Auditory startle (0–1) 1.0  0 1.0  0 0.95  0.05
Corneal reflex (0–2) 1.0  0 1.0  0 0.88  0.1
Pinna reflex (0–2) 0.92  0.08 0.83  0.16 0.6  0.1
Toe pinch (0–4) 2.5  0.1 2.8  0.2 1.5  0.2c
Trunk curl (0–1) 0.87  0.09 0.86  0.09 0.95  0.04
Reactivity
Touch escape (1–3) 1.8  0.3 2.5  0.3 0.6  0.1d
Transfer arousal (1–6) 4.5  0.4 4.0  0.4 2.8  0.3c
Provoked dowel biting (0–1) 0.4  0.1 0.6  0.2 0.3  0.1
Positional passivity (0–4)a 0.08  0.08 0 1.0  0.15d
Strength/coordination
Grip strength (1–4) 2.4  0.2 2.9  0.3 1.2  0.2d
Wire maneuver (1–4)a 0.8  0.4 0.3  0.3 3.1  0.2d
Vertical pole (1–4) 2.6  0.2 2.2  0.4 1.4  0.1d
Motor abilities
Gait (0–3)a 0 0 0.85  0.2c
Horizontal activity (movements) 503.8  67 547.0  108 260.5  34c
Vertical activity (movements) 63.2  14 55.8  11 28.3  7d
Time active 74.4  2% 72.6  4% 56.9  3%
Assessment of general health, neurologic function and activity of 15-wk-old carbyoxypeptidase E knockout mice.
a Gradient scales in which increasing number indicates decreasing vigor, strength, or excitement. Different from /, b P  0.05; c P  0.01;
d P  0.001.
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with WT controls (Fig. 3D). Although at 30 wk KO males and
females had similar levels of locomotion during the dark
phase, null females were less active than the males during the
light phase at both 12 and 30 wk of age. Indeed, KO females
demonstrated the greatest reduction in activity with age,
whereas the decline seen with KO males was similar to that
observed with WT controls. When rearing activity was con-
sidered, WT males and females displayed more vertical ac-
tivity than KO mice regardless of age (data not shown).
Rearing declined with age for all mice; however, it declined
most precipitously for KO females who were less active than
all other groups. By contrast, stereotypy scores were not
distinguished by genotype and were reduced as the animals
aged (data not shown).
Abnormalities in metabolism can contribute to obesity.
We used indirect calorimetry to evaluate how the animals
used their nutrients when activity levels were very low
(Fig. 4, A and B). Although energy expenditure was not
distinguished by genotype at 12 wk of age, older WT males
and females expended more energy than the KO mice.
These data show that basal metabolic rates are reduced in
the older homozygous mutants. An examination of
CO2/O2 exchange ratios reveals this respiratory quotient
to be higher in null than WT animals at 12 and 30 wk of
age (Fig. 4, C and D). This effect was significant for
younger KO females and older null males.
Analysis of body fat content
Body fat content of 45- to 52-wk-old mice was analyzed by
NMR. Male and female KO mice had body fat contents at
39.7% and 54.1% of their respective body weights, compared
with 18.4% and 20.8% of weights from male and female WT
animals.
Analysis of plasma leptin and CART from CPE KO mice
Leptin and CART, two peptides involved in feeding and
energy expenditure (30, 31), were analyzed in plasma from
WT and KO mice at 40–62 wk of age. KO animals (average
weight 76.5  3.9 g, n  8) had plasma leptin levels at 131.7 
17.2 ng/ml. Age-matched WT mice (average weight 36.2 
1.6 g, n  9) had leptin levels approximately four times lower
(31.7  6.6 ng/ml).
CART is synthesized as a precursor and processed to ac-
tive CART I (5.1kD) and CART II (4.4 kDa) (32). To determine
the molecular forms of CART in plasma of KO and WT mice,
samples were analyzed by the Ciphergen protein chip assay
(Fig. 5). Plasma from WT males contained primarily fully-
processed CART II (4.4 kDa) and some CART I (5.1 kDa); no
fully processed CART I or CART II were detected in plasma
from KO mice. By contrast, concentrations of CART 6.2 kDa
(Fig. 5) and 8.1 kDa intermediates (data not shown) were
greatly enhanced in KO mice. Some pro-CART was also
found in KO animals, but not in the WT controls (data no
shown). Profiles from WT and KO females were similar to
those for WT and KO males, respectively.
Development of diabetes in CPE KO mice
Fasting levels of glucose and insulin-like IR in plasma were
monitored between 10 and 45 wk of age (Fig. 6). Because no
genotype differences were noted between WT and HET an-
imals, their data were collapsed into a single group. Al-
though fasting plasma glucose was not distinguished by
genotype at an early age, levels for both WT/HET and KO
mice increased with age. With respect to males, fasting
plasma glucose concentrations were significantly increased
between 17 and 26 wk of age in KO males to a level approx-
imately 2-fold higher than the WT/HET controls (Fig. 6, top
left). Thereafter, no genotype differences were evident be-
tween males. For KO females, fasting plasma glucose levels
became significantly augmented from 14 wk of age and per-
sisted high throughout the remainder of the study (Fig. 6, top
right). During this time, fasting plasma glucose contents in
null females were increased by at least 2.5-fold over that of
WT controls.
Analyses of fasting insulin contents in plasma revealed
that insulin-like IR was low in WT/HET animals regardless
of sex. By contrast, fasting plasma insulin levels significantly
increased in male and female KO mice at 14–15 wk of age and
remained elevated by 50- to 100-fold throughout life (Fig. 6,
bottom).
HPLC analysis of (pro)insulin from plasma
Forms of insulin-like IR in plasma from 27-wk-old WT and
KO animals were analyzed by HPLC. Greater than 90% of the
insulin-like IR loaded onto the column from plasma of KO
FIG. 2. Body weight as a function of age for CPE KO mice. A, Weights
of male and female WT/HET and KO mice were recorded from 1–48
wk of age. n  50 animals from each group. B, Photograph of WT and
CPE KO mice at 40 wk of age depicting the obesity and size of the null
animal.
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mice was recovered in fractions where authentic proinsulin
elutes (Fig. 7). No mature insulin was detected, although
small quantities cannot be discounted. No insulin-like IR
material was detectable in WT plasma after HPLC because of
the low levels in the original sample (data not shown). The
elution profiles of the standards used are consistent with the
previously described immunoreactive profiles of these mol-
ecules (33).
Glucose tolerance and insulin resistance
Glucose tolerance was examined in KO and WT mice at
approximately 12 and 30 wk of age (Fig. 8). Following in-
FIG. 3. Food intake and locomotor activity for
CPE mice. Food consumption for male and fe-
male WT and KO mice at approximately 12 (A)
and 30 wk of age (B) during the light and dark
phases of the light-dark cycle. C and D, Spon-
taneous locomotor activity from the same WT
and KO mice. *, P  0.05 from WT controls
during the light or dark phase of the light-dark
cycle, n  6–10 mice/group.
FIG. 4. Basal metabolic rates and respiratory ex-
change ratios in CPE mice. Energy expenditure was
measured in resting WT and CPE KO mice at ap-
proximately 12 (A) and 30 wk of age (B). C and D, The
respiratory quotient in the same mice. *, P  0.05
from WT controls, n  6–9 mice/group.
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jection of glucose, plasma glucose levels were significantly
higher in KO mice at 12 and 30 wk compared with the WT
controls. Although glucose levels decreased over time in the
KO mice, the levels remained significantly elevated com-
pared with WT animals. Levels of plasma glucose were
higher for KO females than KO males at both age groups
after glucose administration. Overall, male and female WT
mice did not differ in their responses to glucose challenge
at either age.
Insulin resistance in nonfasted CPE KO and WT mice was
FIG. 5. Representative surface-enhanced laser desorption/ionization-time of flight mass spectrometry chromatographic profiles of CART-like
IR in serum from male WT and CPE KO mice. The sera from WT and KO animals were analyzed using a PG20 ProteinChip, which was coupled
with anti-CART (55–102). The relative intensity (percentage) in mass/charge is plotted for each peptide and shown for the region between 4000
and 6500 Daltons. Active forms of CART, CART I (4.4 kDa), and CART II (5.1 kDa) were present in serum from WT (solid line) mice, but not
in CPE KO animals (dashed line). Intermediate forms of CART [either 6.2 kDa or 8.1 kDa (not shown)] were found in greater amounts in KO
vs. WT animals. The profiles from sera of the female mice were similar to that for WT and KO males.
FIG. 6. Fasting plasma glucose and insulin levels in CPE mice. Animals were fasted for 6–8 h and blood was collected from mice at various
ages. Because no significant differences were detected between WT and HET animals, their data were combined and compared with KO mice.
Top, Fasting plasma glucose levels in WT/HET and KO males (left) and females (right). Bottom, Fasting plasma insulin-like IR in the same
mice. n  19–25 mice/group. Data are reported as a 6-wk rolling average.
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studied at approximately 12 and 30 wk of age (Fig. 9). At 12 wk
of age, WT and KO females had higher baseline levels of glucose
compared with values at 30 wk. After insulin administration,
levels of plasma glucose were reduced in both WT and KO
females; however, the response in KO females was blunted with
respect to WT controls. Both WT and KO males at 12 wk of age
showed similar responses to insulin over the 60 min. By 30 wk
of age, however, plasma glucose levels in both male and female
KO mice were suppressed significantly to lesser extents than
male and female WT controls. Male and female WT mice at 30
wk were more responsive to insulin administration than the
same groups at 12 wk of age.
To examine the basis of insulin tolerance in more detail,
epididymal adipose cells from 50- to 60-wk-old animals were
tested for insulin and proinsulin resistance. U-[14C]-glucose
uptake into isolated cells, a measure of glucose transport
activity, was measured in the presence of supramaximal
concentrations of insulin or proinsulin. In cells from WT male
FIG. 7. Representative chromatographic profile of proin-
sulin and insulin in plasma from CPE null mice. Materials
in plasma from KO females (27 wk old) were separated by
reversed-phase HPLC. The column was equilibrated in 65%
buffer A [50 mM phosphoric acid, 20 mM triethylamine, and
50 mM sodium perchlorate (pH 3.0)] and 35% buffer B (90%
acetonitrile in water). After injection, buffer B was main-
tained at 35% for 5 min and then increased to 40% over the
next 25 min. Fractions were assayed for insulin-IR by RIA.
Approximately 90% of the injected insulin-IR was recovered
in fractions 22–24. Arrows indicate the fractions where
authentic insulin and proinsulin elute. *, A nonspecific
peak present to the same extent in the WT sample (data not
shown).
FIG. 8. Glucose tolerance in CPE mice at approx-
imately 12 and 30 wk of age. Male (A and B) and
female (C and D) WT and KO animals were fasted
overnight, blood was collected the next morning
(0 min), and animals were administered a solu-
tion of 25% D-glucose (ip, 11.1 mmol/kg body
weight). Blood was collected 15, 30, 60, 120, and
180 min after injection and plasma glucose levels
were determined. *, P  0.05 from the WT control,
n  14–18 mice/group.
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and female animals, both insulin and proinsulin stimulated
glucose transport activity by approximately 2.5-fold (data
not shown). The corresponding responses in cells from KO
males were reduced by 50%, whereas the cells from KO
females were almost totally unresponsive (data not shown).
Reproductive status of CPE mice
Fertility of CPE mice was examined daily after pairing
male and female WT or male and female KO animals for 30 d.
Approximately 89% (17/19 animals) of the WT females be-
came pregnant, whereas only 5% (1/20 animals) of the KO
females showed evidence of pregnancy. The litter sizes were
similar between WT (6.9  0.3 pups) and KO dams (six pups).
Analysis of hypothalamic GnRH (a major regulator of
reproduction in mammals) by A772 antiserum revealed that
mature GnRH-like IR was reduced by approximately 75% in
KO males and by 50% in null females compared with their
respective WT controls (Fig. 10A). However, assay of the
same samples with the B9 antiserum showed comparable
levels of GnRH-like IR between WT and KO males, and at
least 2.2-fold more GnRH-like IR in KO females compared
with WT controls (Fig. 10B). To evaluate processing, the ratio
of A772 IR (fully processed GnRH) to B9 IR (GnRH plus
intermediates) was calculated. This ratio was reduced by
more than 78% in both male and female KO mice (Fig. 10C).
Neurological and behavioral status
No main effects of sex or a sex by genotype interaction were
observed for any test. Hence, results were collapsed across sex
and presented as the total number of animals in each genotype.
Behavioral performance of HET mice did not differ significantly
from WT animals on any measure (Table 1). The condition of
the fur (e.g. social interaction) was similar in all animals and all
mice were well groomed. The KO mice at 15 wk of age exhibited
less abdominal muscle tone than WT and HET controls and
several KO animals displayed a mild tremor.
Although KO mice had reduced responses in all reflexes
tested, only visual placing and toe pinch were significantly
impaired. KO animals were also lethargic and significantly
less responsive in measures of reactivity (e.g. touch escape,
transfer arousal, and, positional passivity); however, they
did not have significantly reduced responses to provoked
dowel biting. Compared with WT and HET animals, the KO
mice were significantly impaired in almost every test of
strength and coordination (grip strength, wire maneuver,
and vertical pole), and motor performance (e.g. gait, hori-
zontal activity, and vertical activity; time active).
Morbidity
Under conditions of normal colony maintenance (i.e. with-
out invasive experimentation), six of 12 KO females and five
FIG. 9. Insulin tolerance test in CPE mice.
At approximately 12 and 30 wk of age, non-
fasted male and female CPE WT and KO
mice were weighed, and an initial plasma
glucose determination was made. The mice
were given 1U/kg (ip) recombinant human
insulin and glucose clearance was moni-
tored at 15, 30, and 60 min post injection.
*, P  0.05 from the WT control, n  6–12
mice/group.
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of 20 KO males have died for unknown reasons. Of these 11
mice, seven of them (four males and three females) died
between the ages of 32 and 52 wk. In comparison, two of 44
WT animals died by 10 wk of age and three of 106 HET
animals died at 23, 38, and 65 wk of age, respectively.
Discussion
CPE KO mice develop obesity
Body weight measurements revealed that the CPE KO
mice were initially lighter in weight than the WT animals but
became heavier by 8 wk of age. This enhancement in body
weight continued, so that, by 40 wk of age KO weights
exceeded those of the WT controls by 2- to 3-fold. KO females
appeared to be more affected than the KO males because the
weight difference attributed to gender was overcome earlier,
such that male and female KO mice had overlapping pro-
gressions in weight gain. This is in contrast to the CPEfat/fat
mouse where weight differences between male and female
mutants was maintained until adulthood (34). Hence, the
CPE KO mice present a more severe obese phenotype. In-
deed, CPEfat/fat mice did not appear to get as heavy as the KO
mice, although this may be because of mouse strain differ-
ences. Analyses of body composition by NMR confirmed that
the weight gain in the KO mice was primarily because of an
accumulation of body fat, accounting for approximately 40%
and more than 50% of the body weight of male and female
mice, respectively. Part of the male KO weight gain could be
explained by increased body length, but this does not appear
to be the case for KO and WT females whose body lengths
were similar. Analysis of food consumption, showed that KO
females consumed more food by 12 wk of age than WT
controls. Again, this is in contrast to CPEfat/fat mice whose
food intake at similar ages were not different from WT ani-
mals (34). Whereas KO and WT males showed no difference
in food or water consumption at 12 wk, similar to the male
CPEfat/fat mice at that age, the KO males did display an
enhanced food consumption at 30 wk.
This increased consumption is likely a result of improper
FIG. 10. Hypothalamic GnRH levels in CPE mice.
A, GnRH-like IR as measured with the A772 anti-
serum in male and female WT and KO mice. The
A772 recognizes the fully processed GnRH and does
not bind any intermediates with extended amino
acids at the C terminus. B, GnRH-like IR as mea-
sured with the B9 antiserum that recognizes the
decapeptide and all GnRH intermediates. C, The
ratio of GnRH-like IR as quantified with the A772
and B9 antiserum. *, P  0.05 from the WT controls,
n  10 mice/group.


















Y user on 15 O
ctober 2021
signaling in the control of eating behavior that involves the
balance of orexigenic and anorectic neuropeptides in the
hypothalamus (35). Proper maturation of these neuropep-
tides requires correct trafficking and processing within these
peptidergic neurons, of which CPE plays an important role.
One of these neuropeptides, CART, functions as an anorectic
peptide by inhibiting eating behavior and is secreted from
the hypothalamus in response to leptin (30, 31). However, it
is only active when processed to its mature form. Because
fully processed levels of CART are absent in KO mice, these
mutants should have less control over their eating behavior
compared with WT animals. This processing deficit may
contribute to their obesity by augmented eating.
In addition to consuming more food, we also observed that
the KO animals exhibited reduced spontaneous activity dur-
ing the light phase of the light-dark cycle, they had reduced
energy expenditures, and they appeared to use less of their
fat as calories than the WT controls. These findings indicate
that for CPE KO animals, physical inactivity, reduced basal
metabolism, and reduction in fat expenditure may contribute
to enhanced lipid stores and obesity of the CPE KO animals.
CPE KO mice become diabetic
Both male and female CPE KO mice became hyperglyce-
mic by approximately 17 wk of age. However, in glucose
tolerance tests, glucose handling was abnormal even in the
12 wk group of KO animals. As observed with the obesity
and feeding behavior of the KO females at this age, glucose
clearance was significantly more impaired in KO females
than males, suggesting that impaired glucose clearance in the
KO females is an additional factor contributing to the sever-
ity of their obesity phenotype. Indeed, although KO males
recovered from the diabetes later in life, high fasting levels
of glucose persisted in the null females, although some dim-
inution was observed after approximately 35 wk. This re-
versal in diabetes was previously observed in the CPEfat/fat
males; however, in contrast to the CPE KO females, the
CPEfat/fat females exhibited only mild hyperglycemia (34).
The rise in fasting plasma glucose was accompanied by an
augmentation in the fasting plasma insulin-like IR, which
was identified by HPLC as proinsulin. This rise in proinsulin
began at 15–20 wk, and it remained elevated by 50- to 100-
fold throughout life compared with WT controls. For KO
males, the high levels of proinsulin were maintained through
40–45 wk; 10 wk after fasting glucose levels had returned to
near WT levels. These data suggest that, for the KO males,
the recovery from diabetes may be because of the very high
levels of circulating proinsulin because proinsulin is known
to have biological activity, but at 1% of the efficacy of normal
insulin (36). However, this does not appear to be the case for
KO females whose levels of proinsulin remain as high as for
KO males yet they continue to be hyperglycemic. As a pos-
sible explanation, this dichotomy may occur early in life as
young KO males (12 wk) respond relatively normally to
insulin challenge, whereas it is blunted in KO females. Ad-
ditionally, in older animals (50–60 wk of age), glucose up-
take activity in adipose cells is completely resistant in fe-
males, whereas in males it is reduced by 50%.
Maintenance of normal plasma glucose levels beyond 37
wk in the KO males could also be because of the high levels
of leptin, which is reported to increase hepatic insulin sen-
sitivity (37). Enhanced glucose uptake into the liver could
account for the reversal of the hyperglycemia if this effect
was specific for males only. Enlarged livers with abundant
fat deposits were observed in a majority of these CPE
KO mice (Cawley, N. X., and Y. P. Loh, unpublished
observations).
CPE KO mice are lethargic and exhibit defective
muscle physiology
To explore the nature of the physical inactivity that may
contribute to the obesity, neurobehavioral evaluations of the
CPE KO mice were performed. The observations showed
that the KO animals had reduced performance in all tests that
required muscle strength or coordination. For example, def-
icits occurred in reflexes of visual placing and toe pinch; the
reactivity measures of touch escape, transfer arousal, and
positional passivity; and the measures of strength and co-
ordination such as grip strength, wire maneuver and vertical
pole climbing. In addition, all measures of motor abilities in
the open field were reduced in the CPE KO animals. Al-
though the greater body weight of the CPE KO animals may
contribute to their inactivity, the reduction of abdominal tone
as early as 15 wk of age suggests that a defect in muscle
physiology could contribute to the lethargy of the CPE KO
animals. In fact, metabolic abnormalities in muscle because
of the obesity, such as reduced oxidative enzyme activity
(38), could account for some of these deficits. Despite these
points, KO performance on reflexes that do not require ex-
tensive movements of the body such as the corneal reflex,
pinna reflex, trunk curl, or provoked dowel biting were also
somewhat reduced, suggesting that CPE KO mice may also
possess some sensory/neural defects.
Reproductive deficits in CPE KO mice
The results of the mating studies showed that although the
KO animals are not completely infertile, reproduction is se-
verely impaired. Successful reproduction requires an intact
hypothalamic-pituitary-gonadal system. Within this feed-
back system, GnRH is the only major reproductive peptide.
Because CPE is an exopeptidase responsible for removing
basic amino acids from the C terminus of peptides, we pos-
tulated some time ago that this enzyme was critical in pro-
cessing the pro-GnRH to the bioactive decapeptide (25, 26).
Analyses of GnRH-like IR with the A772 antiserum suggests
that fully-processed GnRH levels in hypothalamus are sig-
nificantly depressed in KO animals. By contrast, when con-
centrations are measured with the B9 antiserum, levels of
GnRH and its intermediates appear to be similar to or even
enhanced above values for the WT controls. Given the an-
tigenic determinants of the two antisera (26, 28), our results
suggest that processing of C-terminal extended GnRH in-
termediates in hypothalamus is severely impaired in the CPE
KO mouse and that this abnormality likely contributes to the
sub-fertility in these animals. Similar findings have been
reported in the CPEfat/fat mouse (27).
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Role of CPE in nervous system function
Our studies on the CPE KO mouse indicate that CPE is
important at many different physiological levels. Most in-
triguing are the neurological deficits. Because CPE plays a
critical role in the processing (39, 40) and sorting (3, 9, 10) of
peptide hormones and neuropeptides in the RSP, it is not
surprising that lack of regulated secretion of mature neu-
ropeptides in the central nervous system can exert effects on
neurotransmission and, perhaps, neuronal development of
these mice. Indeed, deficits in neurotransmission have been
reported at the neuromuscular junction in a mutant CPE null
C. elegans (22) and at photoreceptors in the retina of CPE KO
mice (41). A role of CPE in neurodevelopment is highly
plausible because CPE is expressed in the developing ner-
vous system during the time of synapotgenesis (42) before
expression of the endocrine system in the embryo. Further-
more, our recent studies indicate that sorting and activity-
dependent secretion of brain-derived neurotrophic factor
from embryonic central nervous system neurons of the CPE
KO mouse is obliterated (Lou, H., S.-K. Kim, E. Zaitsev, C. R.
Snell, B. Lu, and Y. P. Loh, submitted for publication). This
deficit could have a profound effect on neural development,
synaptic plasticity, and memory (43).
In summary, studies on the CPE KO mouse have provided
new insights into the possible roles of CPE, particularly
within the nervous system that heretofore have not been
recognized. Additionally, many challenges lie ahead in un-
derstanding the mechanisms underlying the onset of obesity
and the reversal of hyperglycemia in CPE KO mice. Con-
tinued studies on this mouse model will provide exciting
new insights into the important roles CPE play, beyond that
of a prohormone processing enzyme (1) and sorting receptor
(3, 10) in endocrine and neuroendocrine cells.
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